While, EPO can disconnect macrophages by diminishing the activity of NF-κB, in vivo. Thus, macrophage regulation could be one of the mechanisms that explain the anti-fibrotic effect of EPO in CKD [19,22-26]. Here, EPO is linked to chronic kidney disease.